Report Detail

According to our (Global Info Research) latest study, the global Pharmaceutical Grade Isonicotinamide market size was valued at US$ 27.89 million in 2025 and is forecast to a readjusted size of US$ 38.1 million by 2032 with a CAGR of 4.6% during review period.
Pharmaceutical grade isonicotinamide (pyridine-4-carboxamide) is the amide form of isonicotinic acid. It is an isomer of nicotinamide, with the carboxamide group positioned at the 4-position. Isonicotinamide is widely used in the pharmaceutical industry as a key intermediate in the synthesis of various drugs, particularly anti-tuberculosis medications and other therapeutic agents. Its high purity and stability meet stringent pharmaceutical standards, making it suitable for a range of high-demand medical applications.
This report is a detailed and comprehensive analysis for global Pharmaceutical Grade Isonicotinamide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pharmaceutical Grade Isonicotinamide market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Pharmaceutical Grade Isonicotinamide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Pharmaceutical Grade Isonicotinamide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Pharmaceutical Grade Isonicotinamide market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Grade Isonicotinamide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Grade Isonicotinamide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hebei Yanuo Bioscience, Veeprho, AK Scientific, SynZeal, Bide Pharmatech, Xiangshui Henryda Tech Chemical, Taizhou Quick Chemical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pharmaceutical Grade Isonicotinamide market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity 99%
Others
Market segment by Application
Cephalosporin Drug Intermediates
Others
Major players covered
Hebei Yanuo Bioscience
Veeprho
AK Scientific
SynZeal
Bide Pharmatech
Xiangshui Henryda Tech Chemical
Taizhou Quick Chemical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Grade Isonicotinamide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharmaceutical Grade Isonicotinamide, with price, sales quantity, revenue, and global market share of Pharmaceutical Grade Isonicotinamide from 2021 to 2026.
Chapter 3, the Pharmaceutical Grade Isonicotinamide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Grade Isonicotinamide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pharmaceutical Grade Isonicotinamide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical Grade Isonicotinamide.
Chapter 14 and 15, to describe Pharmaceutical Grade Isonicotinamide sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pharmaceutical Grade Isonicotinamide Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Purity 99%
    • 1.3.3 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Pharmaceutical Grade Isonicotinamide Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Cephalosporin Drug Intermediates
    • 1.4.3 Others
  • 1.5 Global Pharmaceutical Grade Isonicotinamide Market Size & Forecast
    • 1.5.1 Global Pharmaceutical Grade Isonicotinamide Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Pharmaceutical Grade Isonicotinamide Sales Quantity (2021-2032)
    • 1.5.3 Global Pharmaceutical Grade Isonicotinamide Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Hebei Yanuo Bioscience
    • 2.1.1 Hebei Yanuo Bioscience Details
    • 2.1.2 Hebei Yanuo Bioscience Major Business
    • 2.1.3 Hebei Yanuo Bioscience Pharmaceutical Grade Isonicotinamide Product and Services
    • 2.1.4 Hebei Yanuo Bioscience Pharmaceutical Grade Isonicotinamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Hebei Yanuo Bioscience Recent Developments/Updates
  • 2.2 Veeprho
    • 2.2.1 Veeprho Details
    • 2.2.2 Veeprho Major Business
    • 2.2.3 Veeprho Pharmaceutical Grade Isonicotinamide Product and Services
    • 2.2.4 Veeprho Pharmaceutical Grade Isonicotinamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Veeprho Recent Developments/Updates
  • 2.3 AK Scientific
    • 2.3.1 AK Scientific Details
    • 2.3.2 AK Scientific Major Business
    • 2.3.3 AK Scientific Pharmaceutical Grade Isonicotinamide Product and Services
    • 2.3.4 AK Scientific Pharmaceutical Grade Isonicotinamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 AK Scientific Recent Developments/Updates
  • 2.4 SynZeal
    • 2.4.1 SynZeal Details
    • 2.4.2 SynZeal Major Business
    • 2.4.3 SynZeal Pharmaceutical Grade Isonicotinamide Product and Services
    • 2.4.4 SynZeal Pharmaceutical Grade Isonicotinamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 SynZeal Recent Developments/Updates
  • 2.5 Bide Pharmatech
    • 2.5.1 Bide Pharmatech Details
    • 2.5.2 Bide Pharmatech Major Business
    • 2.5.3 Bide Pharmatech Pharmaceutical Grade Isonicotinamide Product and Services
    • 2.5.4 Bide Pharmatech Pharmaceutical Grade Isonicotinamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Bide Pharmatech Recent Developments/Updates
  • 2.6 Xiangshui Henryda Tech Chemical
    • 2.6.1 Xiangshui Henryda Tech Chemical Details
    • 2.6.2 Xiangshui Henryda Tech Chemical Major Business
    • 2.6.3 Xiangshui Henryda Tech Chemical Pharmaceutical Grade Isonicotinamide Product and Services
    • 2.6.4 Xiangshui Henryda Tech Chemical Pharmaceutical Grade Isonicotinamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Xiangshui Henryda Tech Chemical Recent Developments/Updates
  • 2.7 Taizhou Quick Chemical
    • 2.7.1 Taizhou Quick Chemical Details
    • 2.7.2 Taizhou Quick Chemical Major Business
    • 2.7.3 Taizhou Quick Chemical Pharmaceutical Grade Isonicotinamide Product and Services
    • 2.7.4 Taizhou Quick Chemical Pharmaceutical Grade Isonicotinamide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Taizhou Quick Chemical Recent Developments/Updates

3 Competitive Environment: Pharmaceutical Grade Isonicotinamide by Manufacturer

  • 3.1 Global Pharmaceutical Grade Isonicotinamide Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Pharmaceutical Grade Isonicotinamide Revenue by Manufacturer (2021-2026)
  • 3.3 Global Pharmaceutical Grade Isonicotinamide Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Pharmaceutical Grade Isonicotinamide by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Pharmaceutical Grade Isonicotinamide Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Pharmaceutical Grade Isonicotinamide Manufacturer Market Share in 2025
  • 3.5 Pharmaceutical Grade Isonicotinamide Market: Overall Company Footprint Analysis
    • 3.5.1 Pharmaceutical Grade Isonicotinamide Market: Region Footprint
    • 3.5.2 Pharmaceutical Grade Isonicotinamide Market: Company Product Type Footprint
    • 3.5.3 Pharmaceutical Grade Isonicotinamide Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pharmaceutical Grade Isonicotinamide Market Size by Region
    • 4.1.1 Global Pharmaceutical Grade Isonicotinamide Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Pharmaceutical Grade Isonicotinamide Consumption Value by Region (2021-2032)
    • 4.1.3 Global Pharmaceutical Grade Isonicotinamide Average Price by Region (2021-2032)
  • 4.2 North America Pharmaceutical Grade Isonicotinamide Consumption Value (2021-2032)
  • 4.3 Europe Pharmaceutical Grade Isonicotinamide Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Pharmaceutical Grade Isonicotinamide Consumption Value (2021-2032)
  • 4.5 South America Pharmaceutical Grade Isonicotinamide Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Pharmaceutical Grade Isonicotinamide Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Pharmaceutical Grade Isonicotinamide Sales Quantity by Type (2021-2032)
  • 5.2 Global Pharmaceutical Grade Isonicotinamide Consumption Value by Type (2021-2032)
  • 5.3 Global Pharmaceutical Grade Isonicotinamide Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Pharmaceutical Grade Isonicotinamide Sales Quantity by Application (2021-2032)
  • 6.2 Global Pharmaceutical Grade Isonicotinamide Consumption Value by Application (2021-2032)
  • 6.3 Global Pharmaceutical Grade Isonicotinamide Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Pharmaceutical Grade Isonicotinamide Sales Quantity by Type (2021-2032)
  • 7.2 North America Pharmaceutical Grade Isonicotinamide Sales Quantity by Application (2021-2032)
  • 7.3 North America Pharmaceutical Grade Isonicotinamide Market Size by Country
    • 7.3.1 North America Pharmaceutical Grade Isonicotinamide Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Pharmaceutical Grade Isonicotinamide Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Pharmaceutical Grade Isonicotinamide Sales Quantity by Type (2021-2032)
  • 8.2 Europe Pharmaceutical Grade Isonicotinamide Sales Quantity by Application (2021-2032)
  • 8.3 Europe Pharmaceutical Grade Isonicotinamide Market Size by Country
    • 8.3.1 Europe Pharmaceutical Grade Isonicotinamide Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Pharmaceutical Grade Isonicotinamide Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pharmaceutical Grade Isonicotinamide Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Pharmaceutical Grade Isonicotinamide Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Pharmaceutical Grade Isonicotinamide Market Size by Region
    • 9.3.1 Asia-Pacific Pharmaceutical Grade Isonicotinamide Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Pharmaceutical Grade Isonicotinamide Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Pharmaceutical Grade Isonicotinamide Sales Quantity by Type (2021-2032)
  • 10.2 South America Pharmaceutical Grade Isonicotinamide Sales Quantity by Application (2021-2032)
  • 10.3 South America Pharmaceutical Grade Isonicotinamide Market Size by Country
    • 10.3.1 South America Pharmaceutical Grade Isonicotinamide Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Pharmaceutical Grade Isonicotinamide Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pharmaceutical Grade Isonicotinamide Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Pharmaceutical Grade Isonicotinamide Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Pharmaceutical Grade Isonicotinamide Market Size by Country
    • 11.3.1 Middle East & Africa Pharmaceutical Grade Isonicotinamide Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Pharmaceutical Grade Isonicotinamide Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Pharmaceutical Grade Isonicotinamide Market Drivers
  • 12.2 Pharmaceutical Grade Isonicotinamide Market Restraints
  • 12.3 Pharmaceutical Grade Isonicotinamide Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pharmaceutical Grade Isonicotinamide and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pharmaceutical Grade Isonicotinamide
  • 13.3 Pharmaceutical Grade Isonicotinamide Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pharmaceutical Grade Isonicotinamide Typical Distributors
  • 14.3 Pharmaceutical Grade Isonicotinamide Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Pharmaceutical Grade Isonicotinamide. Industry analysis & Market Report on Pharmaceutical Grade Isonicotinamide is a syndicated market report, published as Global Pharmaceutical Grade Isonicotinamide Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pharmaceutical Grade Isonicotinamide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report